It is important to note that the TGF-β1/smad pathway and the roles of Smad2 and Smad3 in liver cancer are complex and multifaceted, and further research is needed to fully understand their mechanisms of action and potential therapeutic implications. This evidence concerns the gene TGFB1 and liver cancer.